NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 292 filers reported holding NOVOCURE LTD in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $355,655 | -28.8% | 8,570 | +3.2% | 0.00% | -40.0% |
| Q1 2023 | $499,342 | -18.0% | 8,303 | 0.0% | 0.01% | -28.6% |
| Q4 2022 | $609,025 | -13.0% | 8,303 | -9.8% | 0.01% | -12.5% |
| Q3 2022 | $700,000 | -6.8% | 9,210 | -14.7% | 0.01% | +14.3% |
| Q2 2022 | $751,000 | -37.2% | 10,802 | -25.1% | 0.01% | -12.5% |
| Q1 2022 | $1,195,000 | -2.6% | 14,425 | -11.7% | 0.01% | +14.3% |
| Q4 2021 | $1,227,000 | -38.7% | 16,336 | -5.2% | 0.01% | -41.7% |
| Q3 2021 | $2,002,000 | -47.0% | 17,231 | +1.2% | 0.01% | -47.8% |
| Q2 2021 | $3,777,000 | +101.8% | 17,027 | +20.2% | 0.02% | +76.9% |
| Q1 2021 | $1,872,000 | -25.5% | 14,162 | -2.4% | 0.01% | -27.8% |
| Q4 2020 | $2,512,000 | – | 14,515 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $39,681,000 | 20.12% |
| HARTLINE INVESTMENT CORP/ | 330,672 | $27,866,000 | 5.97% |
| MORGAN JESS S & CO INC | 52,889 | $4,457,000 | 4.37% |
| Darsana Capital Partners LP | 1,350,000 | $113,765,000 | 3.88% |
| Rhenman & Partners Asset Management AB | 350,000 | $29,495,000 | 3.23% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $843,000 | 2.55% |
| Taylor Frigon Capital Management LLC | 38,073 | $3,208,000 | 2.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,500 | $2,991,000 | 1.08% |
| Granite Investment Partners, LLC | 261,315 | $22,021,000 | 1.04% |
| Nicholas Investment Partners, LP | 85,835 | $7,233,000 | 0.74% |